Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eun-Kyoung Breuer

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biochemical and Biophysical Research Communications|March 21, 2018
Inhibition of TACC3 by a small molecule inhibitor in breast cancerLoredana Campo, Eun-Kyoung Breuer
Biomed Research International|September 11, 2015
EMT-Inducing Molecular Factors in Gynecological CancersLoredana Campo, Catherine Zhang, Eun-Kyoung Breuer
Biochemical and Biophysical Research Communications|January 23, 2018
Negative regulation of BRCA1 by transforming acidic coiled-coil protein 3 (TACC3)Jung-Lye Kim, Geun-Hyoung Ha, Loredana Campo, et al.
Anticancer Research|March 2, 2018
Combination Treatment of Polo-Like Kinase 1 and Tankyrase-1 Inhibitors Enhances Anticancer Effect in Triple-negative Breast Cancer CellsGeun-Hyoung Ha, Dong-Young Kim, Eun-Kyoung Breuer, et al.
Biomed Research International|September 20, 2016
Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized MedicineStephen Murata, Catherine Zhang, Nathan Finch, et al.
Plos One|August 13, 2013
TACC3 is essential for EGF-mediated EMT in cervical cancerGeun-Hyoung Ha, Jung-Lye Kim, Eun-Kyoung Breuer, et al.
Oncotarget|November 22, 2017
The role of Rak in the regulation of stability and function of BRCA1Jung-Lye Kim, Geun-Hyoung Ha, Loredana Campo, et al.
Cancer Research|August 20, 2011
ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancerRuozhen Hu, Guang Peng, Hui Dai, et al.
Cell Reports|March 25, 2015
FAK mediates a compensatory survival signal parallel to PI3K-AKT in PTEN-null T-ALL cellsDewen You, Junping Xin, Andrew Volk, et al.
Oncotarget|February 10, 2018
Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancerDaniela F Fukushiro-Lopes, Alexandra D Hegel, Vidhya Rao, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|March 21, 2018
Inhibition of TACC3 by a small molecule inhibitor in breast cancerLoredana Campo, Eun-Kyoung Breuer
Biomed Research International|September 11, 2015
EMT-Inducing Molecular Factors in Gynecological CancersLoredana Campo, Catherine Zhang, Eun-Kyoung Breuer
Biochemical and Biophysical Research Communications|January 23, 2018
Negative regulation of BRCA1 by transforming acidic coiled-coil protein 3 (TACC3)Jung-Lye Kim, Geun-Hyoung Ha, Loredana Campo, et al.
Anticancer Research|March 2, 2018
Combination Treatment of Polo-Like Kinase 1 and Tankyrase-1 Inhibitors Enhances Anticancer Effect in Triple-negative Breast Cancer CellsGeun-Hyoung Ha, Dong-Young Kim, Eun-Kyoung Breuer, et al.
Biomed Research International|September 20, 2016
Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized MedicineStephen Murata, Catherine Zhang, Nathan Finch, et al.
Plos One|August 13, 2013
TACC3 is essential for EGF-mediated EMT in cervical cancerGeun-Hyoung Ha, Jung-Lye Kim, Eun-Kyoung Breuer, et al.
Oncotarget|November 22, 2017
The role of Rak in the regulation of stability and function of BRCA1Jung-Lye Kim, Geun-Hyoung Ha, Loredana Campo, et al.
Cancer Research|August 20, 2011
ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancerRuozhen Hu, Guang Peng, Hui Dai, et al.
Cell Reports|March 25, 2015
FAK mediates a compensatory survival signal parallel to PI3K-AKT in PTEN-null T-ALL cellsDewen You, Junping Xin, Andrew Volk, et al.
Oncotarget|February 10, 2018
Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancerDaniela F Fukushiro-Lopes, Alexandra D Hegel, Vidhya Rao, et al.
Pageof 2